Ku70/80的核表达与乳腺癌中CHEK2生殖系突变有关
Rosik Jakub1, Machaj Filip1,2, Bodnar Daniel1
1Department of Pathology, Pomeranian Medical University, Szczecin, Poland.
概括
在大多数具有CHEK2突变的乳腺癌中,Ku70/80蛋白表达升高. 这一发现表明Ku70/80抑制剂可能针对这些特定的乳腺癌,包括ER阳性亚型.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- Ku70/80蛋白对于通过Ku70/80通路进行DNA双链断裂修复至关重要.
- Ku70/80 抑制剂是潜在的癌症治疗药物,特别是对于过度表达Ku70/80的癌症.
- 乳腺癌中Ku70/80表达和生殖线CHEK2突变之间的关系仍未得到研究.
研究的目的:
- 为了评估Ku70/80蛋白表达在怀有生殖线CHEK2突变的乳腺癌中.
- 为了确定Ku70/80表达水平是否在CHEK2相关和非相关的乳腺癌之间有所不同.
- 确定适合Ku70/80抑制剂治疗的潜在患者亚组.
主要方法:
- 免疫组织化学在225名乳腺癌患者的组织微阵列上进行.
- 针对Ku70/80蛋白的抗体被用于染色.
- 自动计算机图像分析量化核Ku70/80表达.
主要成果:
- 分析的绝大多数乳腺癌都表现出高核Ku70/80表达.
- 一小部分 (3.5%) 的瘤没有Ku70/80表达.
- 与CHEK2无关的乳腺癌相比,CHEK2相关的乳腺癌中观察到显著更高的核Ku70/80表达 (p = 0.009).
- 在雌激素受体 (ER) 阳性亚组中,这种关联仍然显著 (p = 0.03).
结论:
- 这是第一个报告Ku70/80表达与乳腺癌中生殖线CHEK2突变之间的关联的研究.
- 在CHEK2突变乳腺癌中Ku70/80表达升高表明这些瘤可能对Ku70/80抑制剂敏感.
- 与CHEK2相关的乳腺癌,特别是ER阳性亚型,是Ku70/80抑制剂治疗的潜在治疗点.
相关概念视频
The Nucleolus
8.9K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.9K
Cancer-Critical Genes I: Proto-oncogenes
9.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.0K
Nucleotide Excision Repair
3.5K
DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
3.5K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K


